Mega Genomics LtdHKG 6667 Stock Report

Mega Genomics Ltd. operates as a genetic testing platform company. The company is headquartered in Beijing, Beijing and currently employs 386 full-time employees. The company went IPO on 2022-06-22. The firm operates its businesses through three segments. The Consumer Genetic Testing Services segment provides testing for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, pharmacogenetic testing and infectious disease testing. The Cancer Screening Services segment provides Septin9 colorectal cancer screening test, Syndecan-2 (SDC2) colorectal cancer screening test and ring finger protein 180 (RNF180)/Septin9 gastric cancer screening test. The Other Services segment provides genetic research and analysis services to third party research institutions.